BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 11, 2018
View Archived Issues
Jeil Pharmaceutical begins phase I trial of oral JP-1366
Read More
Retrophin and Censa Pharmaceuticals to collaborate on CNSA-001 for PKU
Read More
Horizon Pharma licenses MEDI-4945 from MedImmune
Read More
Appili Therapeutics obtains rights to F. tularensis vaccine
Read More
Cypralis gains exclusive rights to certain cyprolides from Gilead collaboration
Read More
Idorsia describes discovery and structure of T-type calcium channel blocker ACT-709478
Read More
Caladrius studies CLBS-12 in patients with critical limb ischemia
Read More
Phase I study explores use of iC9-CAR19 in relapsed or refractory ALL
Read More
Patient enrollment ongoing in phase I trial of TTC-352 for breast cancer
Read More
Latest follow-up data from phase Ia trial of ProscaVax
Read More
KA34 to enter clinical testing for the treatment of osteoarthritis
Read More
Collegium Pharmaceutical enters agreement to commercialize Nucynta in U.S.
Read More
FDA gives orphan drug status to Avadel's FT-218 for narcolepsy
Read More
Stem cell-derived CAR T-cells persist in simian/human immunodeficiency virus model
Read More
MedDay Pharmaceuticals reviews pipeline at J.P. Morgan meeting
Read More
Twelve-month interim data show sustained IOP reduction with Glaukos' iDose travoprost
Read More
Shionogi and PharmaIN establish research collaboration
Read More
Phase I study of AlphaMedix begins in U.S.
Read More
Skin organoids derived from pluripotent stem cells display hair folliculogenesis
Read More
Sublingual allergy immunotherapy tablet Odactra now available in U.S.
Read More
Nagoya City University, University of Tokyo patent mutant SOD1/derlin-1 interaction inhibitors
Read More
FDA grants orphan status to eflornithine/sulindac combination for pancreatic cancer
Read More
Novel estrogen receptor modulators identified at Roche and Genentech
Read More
AstraZeneca's Fasenra approved in E.U.
Read More
Bristol-Myers Squibb discovers apelin receptor agonists
Read More
Incyte discloses novel PD-1/PD-L1 interaction inhibitors
Read More
Merck & Co. presents new histone deacetylase 6 inhibitors
Read More
Ferring and Chinese Academy of Sciences announce collaboration in reproductive medicine
Read More
Applied Genetic Technologies opens phase I/II study of AGTC-501 in X-linked retinitis pigmentosa
Read More
Galapagos obtains rights to MALT1 inhibitors for inflammatory and/or oncological diseases
Read More
